GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Global Inc (OTCPK:CBGL) » Definitions » EV-to-EBITDA

Cannabis Global (Cannabis Global) EV-to-EBITDA : 0.00 (As of May. 12, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Global EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cannabis Global's enterprise value is $0.00 Mil. Cannabis Global's EBITDA for the trailing twelve months (TTM) ended in May. 2022 was $2.59 Mil. Therefore, Cannabis Global's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for Cannabis Global's EV-to-EBITDA or its related term are showing as below:

CBGL's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 14.76
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-12), Cannabis Global's stock price is $0.0001. Cannabis Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2022 was $-0.022. Therefore, Cannabis Global's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Cannabis Global EV-to-EBITDA Historical Data

The historical data trend for Cannabis Global's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Global EV-to-EBITDA Chart

Cannabis Global Annual Data
Trend Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -136.82 -73.83 -21.75 -1.60 -17.78

Cannabis Global Quarterly Data
Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.78 -17.78 13.16 2.79 3.88

Competitive Comparison of Cannabis Global's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Global's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cannabis Global's EV-to-EBITDA falls into.



Cannabis Global EV-to-EBITDA Calculation

Cannabis Global's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/2.587
=0.00

Cannabis Global's current Enterprise Value is $0.00 Mil.
Cannabis Global's EBITDA for the trailing twelve months (TTM) ended in May. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Global  (OTCPK:CBGL) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cannabis Global's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0001/-0.022
=At Loss

Cannabis Global's share price for today is $0.0001.
Cannabis Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.022.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Cannabis Global EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cannabis Global's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Global (Cannabis Global) Business Description

Traded in Other Exchanges
N/A
Address
520 S. Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071
Cannabis Global manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program primarily focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.
Executives
Jim L. Riley director C/O CANNABIS GLOBAL INC., 520 S GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Ghs Investments, Llc 10 percent owner 0830 SOUTH EASTERN AVENUE, #124-376, LAS VEGAS NV 89123
Hymers Iii R. Leslie director, 10 percent owner 520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Arman Tabatabaei director, officer: CEO, CFO 520 SOUTH GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Lauderdale Holdings, Llc director, 10 percent owner, officer: CEO/President/CFO 1919 NW 19 STREET, FT LAUDERDALE FL 33311
Harmel S Rayat 10 percent owner 700 - 688 WEST HASTINGS STREET, VANCOUVER A1 V6B 1P1
David A Gamache director, officer: SECRETARY/TREASURER/CFO 3905 NATIONAL DRIVE, SUITE 110, BURTONSVILLE MD 20866
Meetesh V Patel director, officer: PRESIDENT/CEO 8775 CENTRE PARK DRIVE, # 210, COLUMBIA MD 21045
Pattiann Hiranandani director 3905 NATIONAL DRIVE, BURTONSVILLE MD 20866

Cannabis Global (Cannabis Global) Headlines